Skip to main content

Philanthropy News

Living Legacies
Fall 2023
Carlos G. Bell, Jr. was an esteemed aeronautical and nuclear engineer, as well as a visionary regarding his philanthropic objectives.
Learn more

 

SARS-CoV-2 in human intestine
September 29, 2022
The Stavros Niarchos Foundation establishes an institute for global infectious disease research with $75 million.
Learn more

 

Nathaniel Heintz
June 13, 2022
Nat Heintz is appointed Director of the Fisher Center for Alzheimer’s Research at Rockefeller.
Learn more

 

Living Legacies
Spring 2022
George and Ruby DeStevens had a lifelong passion for biomedical research and scientific discovery.
Learn more

 

Photo for Kellen press release
December 8, 2021
The Anna-Maria and Stephen Kellen Foundation endows the Women’s Entrepreneurship Fund with a $10 million gift.
Learn more

 

Social Brain
November 15, 2021
A major gift from Michael and Vikki Price launches a new interdisciplinary center, devoted to the neuroscience of social behavior—work that will help us to better understand disorders such as autism, depression, and schizophrenia.
Learn more

 

Bulgari Fellows 2020
May 2021
Bulgari Corporation supports Rockefeller’s COVID-19 research and women scientists.
Learn more

 

Philanthropy News
March 30, 2021
Developer Robert Wennett hopes to catalyze support for potent HIV antibody therapy with gift.
Learn more

 

Philanthropy News
March 29, 2021
The Harrington Discovery Institute renews support of Covid-19 antibody therapy developed at The Rockefeller University.
Learn more

 

Philanthropy News
January 29, 2021
The Fisher Center for Alzheimer’s Research Foundation expands its longstanding partnership with Rockefeller to cure neurodegenerative diseases.
Learn more

 

Philanthropy News
Science and medicine are entering an explosive era of discovery.
Learn about Rockefeller’s new strategic plan: The Convergence of Science and Medicine

 

 

Philanthropy News
More than one-third of Rockefeller laboratories are conducting research on the coronavirus.
Learn more about Rockefeller’s COVID-19 research.